Neurofibromatosis

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Von Recklinghausen disease)
Jump to: navigation, search
Neurofibromatosis
Classification and external resources
ICD-10 Q85.0
ICD-9 237.7
ICD-O: 9540/0
MeSH D017253

WikiDoc Resources for

Neurofibromatosis

Articles

Most recent articles on Neurofibromatosis

Most cited articles on Neurofibromatosis

Review articles on Neurofibromatosis

Articles on Neurofibromatosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Neurofibromatosis

Images of Neurofibromatosis

Photos of Neurofibromatosis

Podcasts & MP3s on Neurofibromatosis

Videos on Neurofibromatosis

Evidence Based Medicine

Cochrane Collaboration on Neurofibromatosis

Bandolier on Neurofibromatosis

TRIP on Neurofibromatosis

Clinical Trials

Ongoing Trials on Neurofibromatosis at Clinical Trials.gov

Trial results on Neurofibromatosis

Clinical Trials on Neurofibromatosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Neurofibromatosis

NICE Guidance on Neurofibromatosis

NHS PRODIGY Guidance

FDA on Neurofibromatosis

CDC on Neurofibromatosis

Books

Books on Neurofibromatosis

News

Neurofibromatosis in the news

Be alerted to news on Neurofibromatosis

News trends on Neurofibromatosis

Commentary

Blogs on Neurofibromatosis

Definitions

Definitions of Neurofibromatosis

Patient Resources / Community

Patient resources on Neurofibromatosis

Discussion groups on Neurofibromatosis

Patient Handouts on Neurofibromatosis

Directions to Hospitals Treating Neurofibromatosis

Risk calculators and risk factors for Neurofibromatosis

Healthcare Provider Resources

Symptoms of Neurofibromatosis

Causes & Risk Factors for Neurofibromatosis

Diagnostic studies for Neurofibromatosis

Treatment of Neurofibromatosis

Continuing Medical Education (CME)

CME Programs on Neurofibromatosis

International

Neurofibromatosis en Espanol

Neurofibromatosis en Francais

Businness

Neurofibromatosis in the Marketplace

Patents on Neurofibromatosis

Experimental / Informatics

List of terms related to Neurofibromatosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Neurofibromatosis is an autosomal dominant genetic disorder. It encompasses a set of distinct genetic disorders that cause tumors to grow along types of nerves and, in addition, can affect the development of non-nervous tissues such as bones and skin. The tumors can grow anywhere on or in the body. Incidence is 1:3,000.

History

Neurofibromatosis was discovered in 1882 by Von Recklinghausen. He wrote on it and published it in Hämochromatose, Tageblatt der Naturforschenden Versammlung.

Joseph Merrick, the Elephant Man, was once considered to have been afflicted with either elephantiasis or neurofibromatosis type I. However, it is now generally believed that Merrick suffered from the very rare Proteus syndrome or perhaps a combination of the two conditions.

Types

Apart from the common form, there are two rarer forms and several even rarer forms:

  • Schwannomatosis is a rare form that is clinically and genetically distinct from types I and II. Multiple Schwannomas (rather than Neurofibromas) occur, and about one-third of patients have these tumors in only one part of the body. Incidence is 1:40,000. The vestibular nerve is spared. Pain is the primary symptom, although numbness, tingling and weakness can also occur. Schwannomas are always benign.

Diagnosis

Symptoms

Neurofibromatosis type 1 - mutation of neurofibromin chromosome 17q11.2

Neurofibromatosis type 2 - mutation of merlin chromosome 22q12

Schwannomatosis - gene involved has yet to be identified

  1. Multiple Schwannomas occur.
  2. The Schwannomas develop on cranial, spinal and peripheral nerves.
  3. Chronic pain, and sometimes numbness, tingling and weakness.
  4. About 1/3 of patients have segmental Schwannomatosis, which means that the Schwannomas are limited to a single part of the body, such as an arm, a leg or the spine.
  5. Unlike the other forums of NF, the Schwannomas do not develop on vestibular nerves, and as a result, no loss of hearing is associated with Schwannomatosis.
  6. Patients with Schwannomatosis do not have learning disabilities related to the disease.

Physical Examination

Skin

Genetics and Hereditability

NF-1 and NF-2 may be inherited in an autosomal dominant fashion, as well as through random mutation.
NF-1 and NF-2 may be inherited in an autosomal dominant fashion, as well as through random mutation.

Neurofibromatosis type 1 is due to mutation on chromosome 17q11.2 , the gene product being Neurofibromin ( a GTPase activating enzyme).[1]

Neurofibromatosis type 2 is due to mutation on chromosome 22q , the gene product is Merlin, a cytoskeletal protein.

Both NF1 and NF2 are autosomal dominant disorders, meaning that only one copy of the mutated gene need be inherited to pass the disorder. A child of a parent with NF1 or NF2 and an unaffected parent will have a 50% chance of inheriting the disorder.

Complicating the question of heritability is the distinction between genotype and phenotype, that is, between the genetics and the actual manifestation of the disorder. In the case of NF1, no clear links between genotype and phenotype have been found, and the severity and specific nature of the symptoms may vary widely among family members with the disorder (Korf and Rubenstein 2005). In the case of NF2, however, manifestations are similar among family members; a strong genotype-phenotype correlation is believed to exist (ibid).

Both NF1 and NF2 can also appear spontaneously through random mutation, with no family history. These spontaneous or sporadic cases account for about one half of neurofibromatosis cases (ibid).

Family

Neurofibromatosis is considered a member of the neurocutaneous syndromes (phakomatoses). In addition to the types of neurofibromatosis, the phakomatoses also include tuberous sclerosis, Sturge-Weber syndrome and von Hippel-Lindau disease. This grouping is an artifact of an earlier time in medicine, before the distinct genetic basis of each of these diseases was understood.

Neurofibromatosis in Pop Culture

In the television series Dallas, the inherited neurofibromatosis of the Barnes family is a driving plot device, though the portrayal of the condition does leave something to be desired in terms of scientific fact.

It has been mentioned as a possible diagnosis many times in the Fox drama House.

The character of Cyst, a mutant from The Hills Have Eyes film remake, appears to suffer from neurofibromatosis, which is shown to afflict his head and hands, and possibly other parts of his body obscured by clothing.

Notable Cases

In November 2006, there was an hour-long documentary on the British television network Channel 4 about Facing the World, an organization that helps children with severe facial disfigurements in developing countries. One of the children featured on the documentary was Arianto, an Indoneasian boy who suffered from a severe form of neurofibroma resulting in hemifacial giganticism.

See Also

Neurofibroma

References

  • Korf, Bruce E. and Allan E. Rubenstein. 2005. Neurofibromatosis: A Handbook for Patients, Families, and Health Care Professionals.

It is also small or large lumps which penertrate through the skin and can be quite painful but surgery can help remove these

External links

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 . de:Neurofibromatosefr:Neurofibromatose ja:神経線維腫症 no:Nevrofibromatose nl:Neurofibromatose

Personal tools
In other languages